Drug-delivery vehicles based on reversed liquid crystalline phase materials

Details for Australian Patent Application No. 2004280229 (hide)

Owner Lyotropic Therapeutics, Inc.

Inventors Anderson, David M.; Cameransi, Benjamin G. Jr.

Agent Halfords IP

Pub. Number AU-B-2004280229

PCT Pub. Number WO2005/034872

Priority 60/509,255 08.10.03 US; 10/889,313 13.07.04 US

Filing date 8 October 2004

Wipo publication date 21 April 2005

Acceptance publication date 3 November 2011

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

C09K 19/02 (2006.01) Liquid crystal materials -

C09K 19/06 (2006.01) Liquid crystal materials - Non-steroidal liquid crystal compounds

C11D 17/00 (2006.01) Detergent materials or soaps characterised by their shape or physical properties

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/034872 Priority application(s): WO2005/034872

3 November 2011 Application Accepted

  Published as AU-B-2004280229

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004280233-Non-invasive system for detecting skin cancer

2004280228-Expression of biologically active polypeptides in duckweed